pCDH-MSCV-hCD38-EF1α-GFP+Puro Citations (1)

Originally described in: Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma.
Hu Y, Liu H, Fang C, Li C, Xhyliu F, Dysert H, Bodo J, Habermehl G, Russell BE, Li W, Chappell M, Jiang X, Ondrejka SL, Hsi ED, Maciejewski JP, Yi Q, Anderson KC, Munshi NC, Ao G, Valent JN, Lin J, Zhao J Cancer Res. 2020 Mar 19. pii: 0008-5472.CAN-19-1077. doi: 10.1158/0008-5472.CAN-19-1077. PubMed Journal

---

Articles Citing pCDH-MSCV-hCD38-EF1α-GFP+Puro

Articles
Efficient Generation of Megakaryocyte Progenitors and Platelets From HSPCs via JAK2/STAT3 Signaling. Liu H, Wang L, Liu J, Yuan H, Zhang K, Qiu Y, Zhu F. Adv Sci (Weinh). 2025 Jun;12(23):e2500612. doi: 10.1002/advs.202500612. Epub 2025 Apr 29. PubMed

If you have published an article using this material, please email us at to have your article added to this page.